[New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma].

xlomafota13 shared this article with you from Inoreader [New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma]. Via Association française pour l'étude du cancer Related Articles [New approval: Atezolizumab and bevacizumab for first line of unresecable hepatocellular carcinoma]. Bull Cancer. 2021 Feb 02;: Authors: Minot-This MS, Edeline J PMID: 33546873 [PubMed - as supplied by publisher] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.